Literature DB >> 17468043

Synthesis and NMR spectral studies of N-chloroacetyl-2,6-diarylpiperidin-4-ones.

G Aridoss1, S Balasubramanian, P Parthiban, S Kabilan.   

Abstract

A series of 2,6-diarylpiperidin-4-ones having electron withdrawing chloroacetyl group at the heterocyclic nitrogen were synthesized. Unambiguous characterizations of the synthesized compounds were achieved by one-dimensional ((1)H NMR and (13)C NMR) and two-dimensional (HOMOCOSY, NOESY and HSQC spectra for compounds 8 and 9 and HOMOCOSY spectrum only for 10) NMR spectroscopic data. The conformational preferences of N-chloroacetyl-2,6-diarylpiperidin-4-ones with and without alkyl substituent at C-3 and C-5 (8-14) have also been discussed using the spectral studies. The spectral data and extracted coupling constant values suggest that the compounds 8, 12 and 14 adopt flattened boat conformation whereas the remaining compounds exist in twist-boat conformations in solution with coplanar orientation of the chloroacetyl moiety present at the heterocyclic nitrogen. The substituent parameters for the chloroacetyl moiety on the heterocyclic ring carbons have also been derived and discussed elaborately on the basis of their steric, electronic and gamma-eclipsing interaction. This substituent at the nitrogen causes a substantial change on the chemical shifts of ring carbons and the associated protons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468043     DOI: 10.1016/j.saa.2007.01.013

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  9 in total

1.  Ethyl 1-(2-bromo-propano-yl)-4-hydr-oxy-2,6-diphenyl-1,2,5,6-tetra-hydro-pyridine-3-carboxylate.

Authors:  G Aridoss; D Gayathri; D Velmurugan; M S Kim; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-06-27

2.  1-Chloro-acetyl-2,6-bis-(2-chloro-phen-yl)-3,5-dimethyl-piperidin-4-one oxime.

Authors:  K Ravichandran; P Ramesh; M Rani; S Kabilan; M N Ponnuswamy
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

3.  1-Chloro-acetyl-2,6-bis-(2-methoxy-phen-yl)-3,5-dimethyl-piperidin-4-one.

Authors:  G Aridoss; D Gayathri; D Velmurugan; M S Kim; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-08-29

4.  1-Chloro-acetyl-2,6-bis-(3-fluoro-phen-yl)piperidin-4-one.

Authors:  G Aridoss; D Gayathri; D Velmurugan; M S Kim; Yeon Tae Jeong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-25

5.  Crystal structure of 1-(2-chloro-acet-yl)-3,3-dimethyl-2,6-di-p-tolyl-piperidin-4-one.

Authors:  S Jothivel; Jibon Kotoky; S Kabilan
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-02-13

6.  Synthesis, crystal structure, DFT and molecular docking studies of N-acetyl-2,4-[diaryl-3-azabicyclo[3.3.1]nonan-9-yl]-9-spiro-4'-acetyl-2'-(acetylamino)-4',9-dihydro-[1',3',4']-thiadiazoles: A potential SARS-nCoV-2 Mpro (COVID-19) inhibitor.

Authors:  Ramachandran Rajamanickam; Rani Mannangatty; Jayanthi Sampathkumar; Kabilan Senthamaraikannan; Barathi Diravidamani
Journal:  J Mol Struct       Date:  2022-03-02       Impact factor: 3.841

7.  Synthesis, spectroscopic, topological, hirshfeld surface analysis, and anti-covid-19 molecular docking investigation of isopropyl 1-benzoyl-4-(benzoyloxy)-2,6-diphenyl-1,2,5,6-tetrahydropyridine-3-carboxylate.

Authors:  Arulraj Ramalingam; Murugavel Kuppusamy; Sivakumar Sambandam; Mouna Medimagh; Oluwatoba Emmanuel Oyeneyin; Amirthaganesan Shanmugasundaram; Noureddine Issaoui; Nathanael Damilare Ojo
Journal:  Heliyon       Date:  2022-10-02

8.  Crystal structure of 1-(2-chloro-acet-yl)-2,6-bis-(4-fluoro-phen-yl)-3,3-di-methyl-piperidin-4-one.

Authors:  S Jothivel; Jibon Kotoky; S Kabilan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-09-30

9.  Crystal structures of two new 3-(2-chloro-eth-yl)-r(2),c(6)-diarylpiperidin-4-ones.

Authors:  K Rajkumar; S Sivakumar; R Arulraj; Manpreet Kaur; Jerry P Jasinski; A Manimekalai; A Thiruvalluvar
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.